Martin Treder

Martin Treder

Company: ARJUNA Therapeutics

Job title: Chief Scientific Officer

Seminars:

Derived from A First-In-Class Platform Of Therapeutic Molecular Clusters (TMC), Ag5 Is A Differentiated Molecule That Promises To Be Efficacious In Hard-To-Treat Solid Cancers 1:30 pm

 TMCs are individually unique entities with highly specific physical, chemical and biological properties and represent a new therapeutic modality Ag5 will preferentially kill cancer cells but will spare normal cells due to their REDOX homeostasis, resulting in efficacy in difficult to treat cancers with minimal off-target effects Given that radiotherapy (RT) also kills cells by…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.